Placebo News and Research RSS Feed - Placebo News and Research

Researchers test experimental Zika virus vaccine in mice

Researchers test experimental Zika virus vaccine in mice

An experimental vaccine against Zika virus developed by Brazilian and US researchers has been tested successfully in trials with mice. [More]
Regorafenib drug improves survival rates in patients with hepatocellular carcinoma

Regorafenib drug improves survival rates in patients with hepatocellular carcinoma

Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase III RESORCE trial, presented at the ESMO 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain. [More]
Testosterone therapy improves sexual activity in older men

Testosterone therapy improves sexual activity in older men

Older men with low libido and low testosterone levels showed more interest in sex and engaged in more sexual activity when they underwent testosterone therapy, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. [More]
MOOD-HF supports lack of antidepressant efficacy in HF patients

MOOD-HF supports lack of antidepressant efficacy in HF patients

Escitalopram influences neither depressive symptoms nor medical outcomes when compared with placebo in patients with heart failure and depression, show the MOOD-HF findings. [More]
Experimental lipid-lowering drug improves glucose control in diabetic patients

Experimental lipid-lowering drug improves glucose control in diabetic patients

High triglycerides -- a type of fat, or lipid, in the blood -- increase the risk of heart disease and perhaps type 2 diabetes. For the first time, it has been shown that profoundly lowering triglycerides in diabetics improves their insulin sensitivity over time, which helps them maintain healthy glucose - blood sugar -- levels. [More]
Pioglitazone effective in diabetes patients with NASH

Pioglitazone effective in diabetes patients with NASH

Pioglitazone may halt the progression of nonalcoholic steatohepatitis in patients with prediabetes or Type 2 diabetes, a randomised trial shows. [More]
Scientists explain how engineered anthrax toxin proteins could help eliminate cancerous tumors

Scientists explain how engineered anthrax toxin proteins could help eliminate cancerous tumors

Scientists from the National Institute of Allergy and Infectious Diseases, the National Institute of Dental and Craniofacial Research, and the National Heart, Lung and Blood Institute all parts of the National Institutes of Health, describe how combining engineered anthrax toxin proteins and existing chemotherapy drugs could potentially yield a therapy to reduce or eliminate cancerous tumors. [More]
Researchers tune into previously unknown cross talk between estrogen and progesterone receptors

Researchers tune into previously unknown cross talk between estrogen and progesterone receptors

One of the first clues pathologists look for in tissue from a newly diagnosed breast cancer patient is the estrogen receptor, a nuclear protein that converts hormonal messages in the bloodstream into instructions for the cell about how to behave [More]
Study compares efficacy of SDF in arresting root caries in elders from different fluoridated areas

Study compares efficacy of SDF in arresting root caries in elders from different fluoridated areas

On June 24, 2016, at the 94th General Session & Exhibition of the International Association for Dental Research, researcher Edward Lo, University of Hong Kong, SAR, China, will present a study titled "Effectiveness of SDF in Arresting Root Caries in Different Fluoridated Areas." [More]
Cardiac surgery patients who received omega-3 supplementation experience reduced hospital stays

Cardiac surgery patients who received omega-3 supplementation experience reduced hospital stays

A new meta-analysis published in Clinical Nutrition found that cardiac surgery patients who received omega-3 polyunsaturated fatty acids (compared to placebo) in advance of surgery experienced reduced postoperative cardiac arrhythmias and significantly reduced the length of hospital stay by up to 2.4 days. The results are based on 11 RCT's with 1038 patients. [More]
Statins can lower infection risk by 58% in stroke patients

Statins can lower infection risk by 58% in stroke patients

A Washington State University researcher has found that statin drugs can dramatically lower the risk of infections in stroke patients. [More]
Empagliflozin offers long-term renal protection in Type 2 diabetes

Empagliflozin offers long-term renal protection in Type 2 diabetes

The sodium-glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial. [More]
Novel imaging technique may assist surgeons to improve visualization of ovarian tumors during surgery

Novel imaging technique may assist surgeons to improve visualization of ovarian tumors during surgery

A newly devised tumor-specific fluorescent agent and imaging system guided surgeons in real time to remove additional tumors in ovarian cancer patients that were not visible without fluorescence or could not be felt during surgery. [More]
Cranberries can reduce symptomatic UTIs and avoid chronic suppressive antibiotics

Cranberries can reduce symptomatic UTIs and avoid chronic suppressive antibiotics

Today leading experts on infectious disease and urinary tract infections (UTIs) will gather in London to discuss the alarming state of antibiotic resistance, and present findings from a landmark study that conclusively shows that cranberries can be a nutritional approach to reducing symptomatic UTIs, and as a result, may be a useful strategy to decrease worldwide use of antibiotics. [More]
Study characterizes benefits of over-the-counter sleep aid

Study characterizes benefits of over-the-counter sleep aid

New research shows that an over-the-counter sleep aid helps people suffering from occasional sleep difficulties fall asleep in less than 20 minutes, on average, and improves their reported quality of sleep. [More]
Liraglutide cardioprotective in high-risk Type 2 diabetes patients

Liraglutide cardioprotective in high-risk Type 2 diabetes patients

Findings of the LEADER trial show that liraglutide treatment may confer a reduced risk of cardiovascular events in patients with Type 2 diabetes and a high vascular risk. [More]
Mortality risk high among diabetes patients with prior CV events

Mortality risk high among diabetes patients with prior CV events

Patients with Type 2 diabetes and acute coronary syndromes have a substantially increased risk of death in the 18 months after hospital admission for subsequent major nonfatal cardiovascular events, US researchers report. [More]
Caffeine use may not improve alertness after three nights of restricted sleep

Caffeine use may not improve alertness after three nights of restricted sleep

A new study found that after restricting sleep to 5 hours per night, caffeine use no longer improved alertness or performance after three nights. [More]
Oxytocin hormone plays role in facilitating perception of emotions

Oxytocin hormone plays role in facilitating perception of emotions

Studies have demonstrated that oxytocin (which acts as an hormone and also as a neurotransmitter in the brain) plays a role in facilitating the perception of emotions in other people's facial expressions. [More]
Clinical trial to test efficacy of new drug for chronic cough

Clinical trial to test efficacy of new drug for chronic cough

The National Institute for Health Research has today announced its participation in a clinical trial to test a promising new treatment for chronic cough. If approved, this would be the first new cough drug in 50 years and offer hope to the millions of people living with chronic cough for whom few, if any, effective treatments exist. [More]
Advertisement
Advertisement